Join
Live feed
·
PRReleasevia Quantisnow
Myriad Genetics Inc. logo

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

ByQuantisnow·Wall Street's wire, on your screen.
MYGN· Myriad Genetics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYGN (Myriad Genetics Inc.) and more on Quantisnow.